Get started
Author

Shannon L. Garcia

Observed name: Shannon Garcia
Observed institution: National Jewish Health
ORCID: 0000-0002-4355-245X
Observed ORCID: 0000-0002-4355-245X
OpenAlex ID: A5002432254
Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis
2022 · Evgeny Berdyshev, Elena Goleva, et al. · Allergy · 117
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin
2023 · Donald Y.M. Leung, Robert Bissonnette, et al. · The Journal of Allergy and Clinical Immunology In Practice · 20
Unique skin abnormality in patients with peanut allergy but no atopic dermatitis
2020 · Evgeny Berdyshev, Elena Goleva, et al. · Journal of Allergy and Clinical Immunology · 20
PDF
Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control–matched, phase 4 clinical study (BALISTAD)
2025 · Robert Bissonnette, Elena Goleva, et al. · Journal of the American Academy of Dermatology · 11
Dupilumab Improves Skin Lipid Barrier in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis
2024 · Irina Bronova, Evgeny Berdyshev, et al. · Journal of Allergy and Clinical Immunology · 6
Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis
2022 · Evgeny Berdyshev, Elena Goleva, et al. · Journal of Allergy and Clinical Immunology · 6
Dupilumab treatment restores epithelial barrier in nonlesional and lesional skin in children with atopic dermatitis
2026 · Michael J. Cork, Peck Y. Ong, et al. · Annals of Allergy Asthma & Immunology · 3
PDF
Dupilumab inhibits vascular leakage of blood proteins into atopic dermatitis skin
2023 · Donald Leung, Robert Bissonnette, et al. · Journal of Allergy and Clinical Immunology · 3
PDF
Association of atopic dermatitis with increased risk of anaphylaxis to egg and milk
2019 · Bryce C. Hoffman, Shannon Garcia, et al. · Annals of Allergy Asthma & Immunology · 3
P036 Dupilumab treatment normalizes skin barrier function in children aged 6–11 years with moderate-to-severe atopic dermatitis
2024 · Michael J Cork, Donald Leung, et al. · British Journal of Dermatology · 2
Pediatric Atopic Dermatitis is Associated With More Rapid Recovery of Protein Bound Ceramides After Treatment With Dupilumab
2025 · Evgeny Berdyshev, Elena Goleva, et al. · Journal of Allergy and Clinical Immunology
PDF
53081 Dupilumab Treatment Provides Sustained Improvement in Skin Barrier Function, Clinical Outcomes, and Patient-Reported Outcomes in Patients Aged 6 to 11 Years With Moderate-to-Severe Atopic Dermatitis
2024 · Michael J. Cork, Peck Ong, et al. · Journal of the American Academy of Dermatology
PDF
563 - Dupilumab improves skin lipid composition in atopic dermatitis irrespective of patient filaggrin (FLG) mutation status
2024 · Evgeny Berdyshev, Elena Goleva, et al. · British Journal of Dermatology
ESDR367 - Dupilumab treatment significantly improves skin barrier function in adult and adolescent patients with moderate to severe atopic dermatitis
2022 · Evgeny Berdyshev, Elena Goleva, et al.
Skin Barrier Dysfunction In Patients With Peanut Allergy Without Eczema
2020 · Donald Leung, Elena Goleva, et al. · Journal of Allergy and Clinical Immunology
A Comparison Of Food Allergic Patients With And Without Atopic Dermatitis
2019 · Bryce C. Hoffman, Marco A. Ramirez-Gama, et al. · Journal of Allergy and Clinical Immunology
PDF
Dermatitis atópica en pacientes pediátricos y su relación con algunos factores desencadenantes: Estudio DERMAT-4
2013 · J. Sopeña Corvinos, L. Conte, et al. · Acta pediátrica española/Acta pediátrica española
Works count: 17
Citation count: 191
H-index: 6
I10-index: 4
Year
Topic
Type